[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@jy201506 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::3347605366.png) @jy201506 just a random dude

just a random dude posts on X about $iova, $482m, $12b, $850m the most. They currently have XXX followers and X posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::3347605366/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3347605366/c:line/m:interactions.svg)

- X Week XXXXX +354%
- X Month XXXXXX -XX%

### Mentions: X [#](/creator/twitter::3347605366/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3347605366/c:line/m:posts_active.svg)

- X Month XX -XX%

### Followers: XXX [#](/creator/twitter::3347605366/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3347605366/c:line/m:followers.svg)

- X Week XXX +2%
- X Month XXX +28%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::3347605366/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3347605366/c:line/m:influencer_rank.svg)

### Social Influence

**Social topic influence**
[$iova](/topic/$iova) #7, [$482m](/topic/$482m) #1, [$12b](/topic/$12b) #65, [$850m](/topic/$850m) 25%, [$350m](/topic/$350m) 25%, [if you](/topic/if-you) 25%, [year of](/topic/year-of) 25%, [niche](/topic/niche) 25%, [$legn](/topic/$legn) 25%, [profitable](/topic/profitable) XX%

**Top accounts mentioned or mentioned by**
[@semodough](/creator/undefined) [@oldgoldhawkeye](/creator/undefined)

**Top assets mentioned**
[Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova)
### Top Social Posts
Top posts by engagements in the last XX hours

"i model much higher operating expenses than Truist's $482M number yet see $IOVA become profitable in 2028 much earlier than 2034 by Truist. My key assumptions are 1) 2L NSCLC launch in 2028 and 2) GM reach XX% in 2028. this would lead to a combined product rev of $1.2B operating expense of $850M operation income of $350M in 2028. I bet Truist gave zero credit in 2L NSCLC. If you believe $IOVA's story in 2L NSCLC then it would be a good buy here. Otherwise you should sell"  
[X Link](https://x.com/jy201506/status/1996962420594553117)  2025-12-05T15:18Z XXX followers, 1759 engagements


"basically if one views $IOVA as a niche melanoma company its only modest upside doesnt justify its risk. If one believes $IOVA as a post-PD-1 era IO platform play with potential in multiple solid tumor indications including NSCLC the bet here is highly asymmetric favoring the upside"  
[X Link](https://x.com/jy201506/status/1996975644417069242)  2025-12-05T16:11Z XXX followers, 1233 engagements


"Yescarta and Carvykti are examples of high-margin blockbuster autologous cell therapies. Legend Biotech $LEGN is an example of how a standalone autologous cell therapy company can be profitable. $IOVA will be profitable in 2028. Details see"  
[X Link](https://x.com/jy201506/status/1989770871620141138)  2025-11-15T19:01Z XXX followers, 1922 engagements